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Abstract 
Background: The inability to observe relevant biological processes in vivo significantly restricts human neurodevel‑
opmental research. Advances in appropriate in vitro model systems, including patient‑specific human brain organoids 
and human cortical spheroids (hCSs), offer a pragmatic solution to this issue. In particular, hCSs are an accessible 
method for generating homogenous organoids of dorsal telencephalic fate, which recapitulate key aspects of human 
corticogenesis, including the formation of neural rosettes—in vitro correlates of the neural tube. These neurogenic 
niches give rise to neural progenitors that subsequently differentiate into neurons. Studies differentiating induced 
pluripotent stem cells (hiPSCs) in 2D have linked atypical formation of neural rosettes with neurodevelopmental 
disorders such as autism spectrum conditions. Thus far, however, conventional methods of tissue preparation in this 
field limit the ability to image these structures in three‑dimensions within intact hCS or other 3D preparations. To 
overcome this limitation, we have sought to optimise a methodological approach to process hCSs to maximise the 
utility of a novel Airy‑beam light sheet microscope (ALSM) to acquire high resolution volumetric images of internal 
structures within hCS representative of early developmental time points.
Results: Conventional approaches to imaging hCS by confocal microscopy were limited in their ability to image 
effectively into intact spheroids. Conversely, volumetric acquisition by ALSM offered superior imaging through 
intact, non‑clarified, in vitro tissues, in both speed and resolution when compared to conventional confocal imaging 
systems. Furthermore, optimised immunohistochemistry and optical clearing of hCSs afforded improved imaging at 
depth. This permitted visualization of the morphology of the inner lumen of neural rosettes.
Conclusion: We present an optimized methodology that takes advantage of an ALSM system that can rapidly 
image intact 3D brain organoids at high resolution while retaining a large field of view. This imaging modality can be 
applied to both non‑cleared and cleared in vitro human brain spheroids derived from hiPSCs for precise examination 
of their internal 3D structures. This process represents a rapid, highly efficient method to examine and quantify in 3D 
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Introduction
Human brain organoids represent a revolutionary step 
forward in our ability to investigate human neurode-
velopment through the use of patient-specific human 
induced pluripotent stem cells (hiPSC) to generate 
neural tissues [1–3]. Brain organoids recapitulate a 
more native state of neurodevelopment and thus have 
enabled the in  vitro study of molecular and cellular 
events during early human neurodevelopment [4–7]. 
Early development is also emerging as a key period for 
the emergence of atypical cellular and molecular pro-
cesses thought to contribute to the likelihood of neu-
rodevelopmental disorders such as autism spectrum 
conditions (here after referred to as autism) [8–12]. 
Differentiation of hiPSCs towards a forebrain neuronal 
linage has been shown to recapitulate many of the hall-
marks of early neurodevelopment. Exposure of hiPSCs 
to dual SMAD inhibition results in first the generation 
of neuroepithelium cells that subsequently differentiate 
into neural progenitor cells (NPCs) [13–15]. These cells 
then self-organise around a central lumen: a structure 
called a ‘neural rosette’ [2, 16]. These neural rosettes 
display apical-basal polarity and are thought to repre-
sent the formation of the neural tube during early brain 
development [2, 16, 17]. Formation of neural rosettes 
is crucial for neural development, and perturbations 
in the development of these structures can result in 
premature or abnormal neurogenesis and astrogen-
esis [18]. Several studies using patient-derived hiPSCs 
or human embryonic stem cells (hESCs) have linked 
abnormal neural rosette development and subsequent 
neurogenesis with the pathophysiology of neurodevel-
opmental disorders. For example, NPCs differentiated 
from hESCs generated from individuals with Fragile X 
syndrome, a syndromic form of autism, developed neu-
ral rosettes significantly slower than control hESCs and 
displayed reduced neurogenic potential [19]. Biallelic 
deletion of TSC2, another syndromic form of autism, 
led to hyperfunction of mTORC1 in neural rosettes and 
subsequently, impaired neural differentiation as well as 
increased astroglial differentiation [20]. Furthermore, 
our group has recently observed anomalies in neural 
rosette formation between typical and autistic hiPSCs, 
which appear to have long-term consequences in neu-
ral development [12]. While these studies have pre-
dominately used 2D differentiation protocols, these 
abnormalities in neural rosette formation were also 
recapitulated in 3D preparations [12]. Thus, brain orga-
noids offer a unique opportunity to study pathophysio-
logical mechanisms thought to occur in these disorders 
[9–12, 21].
Several different methods have been used to generate 
3D brain organoids from hiPSCs that recapitulate the 
complex cellular developmental processes involved in the 
generation of specific brain regions [1–3, 22–24]. One 
example is the generation of human cortical spheroids 
(hCSs), which generate dorsal cortical cells [2]. In this 
method, the NPCs that self-organise around the central 
lumen of a neural rosette; these structures also display 
apical-basal polarity, giving rise to post-mitotic neurons 
similar to those found within the forebrain [2, 16, 17]. 
Thus, brain organoids like hCSs provide a 3D in vitro sys-
tem in which mechanisms relevant for human neurode-
velopment and disorders such as autism can be studied.
At present, microscopic analysis of human brain orga-
noids is primarily undertaken by conventional meth-
odologies such as confocal microscopy, which require 
deconstruction of the 3D structure [1, 2, 23]. This 
approach typically involves imaging of 2D tissue slices 
of 3D organoids. This results in a loss of the overall 3D 
tissue-like structural fidelity, and thus, the phenotypic 
resemblance to their original in  vivo correlates. Hence, 
the significance of understanding cellular processes, 
organisation and complexity within a system that mimics 
native human tissue in a 3D state is lost [25]. To image 
intact nervous tissues, high-speed, high-resolution volu-
metric imaging methods are required over large fields-
of-view. New imaging modalities such as, light sheet 
microscopy (LSM) are rapidly gaining importance for 
imaging intact biological specimens [26, 27]. The advan-
tage of using LSM over confocal microscopy is that it 
rapidly (500 × faster) produces 3D volumetric images and 
due to the speed and the specificity of planar illumina-
tion of light sheet when compared with whole-sample 
illumination using confocal microscopy [28]. These fac-
tors reduce the dwell time on each plane imaged produc-
ing less photo-damage to the specimen. However, two 
important factors need to be taken into consideration 
when utilizing this approach: (1) due to lipid content, 
there is considerable loss of excitation signal strength 
and scattering of emission light in imaging of large vol-
umes of tissue that may result in a rapid degradation of 
signal with increasing depth of tissue; and (2) antibodies 
are often accumulate in superficial regions of tissue, due 
the formation of key structures required for the coordination of neurodevelopmental processes in both health and 
disease states. We posit that this approach would facilitate investigation of human neurodevelopmental processes 
in vitro.
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to reduced penetrance of antibodies or permeabilising 
agents deep into tissue, thus reducing visibility of target 
proteins in deeper sections of the tissue.
Several methods are now available to render intact 
tissues optically transparent [29–32]. These aqueous 
clearing techniques reduce light scattering by remov-
ing tissue lipids and replacing them with a clear matrix. 
As reported by Xu et  al. [32], replacing lipids with a 
clear matrix facilitates greater penetration of antibodies. 
The combined effect enables significant preservation of 
both tissue ultrastructure and the accessibility of native 
proteins to antibody probes [29, 31, 32]. To date, only a 
limited number of studies have applied the use of LSM 
or tissue clearing in combination with human brain orga-
noids. For example, Renner and colleagues used cleared 
cerebral organoids to visualise the organisation of ven-
tricles and connectivity between different regions within 
cerebral organoids [33]. However, in this study, the 
authors utilized conventional imaging approaches that 
require the manual reconstruction of 3D structures from 
2D images, which is both time-consuming and may result 
in the loss of the inherent complexities of the biologi-
cal specimen [25]. In a different study, Li and colleagues 
used LSM to examine cortical folding in cerebral orga-
noids [34], but not to examine the organisation of cellular 
structures internally. To our knowledge, few if any studies 
have used a combination of LSM with tissue clearing to 
examine the organisation of internal cellular structures in 
human brain organoids, despite current interest in these 
technologies [25, 28].
In this study, we have: (1) compared conventional tis-
sue processing and image acquisition methods (confocal 
microscopy) against a novel methodology of presenting 
intact 3D tissue for volumetric acquisition using LSM; 
and (2) optimised immunohistochemical approaches 
in combination with tissue clearing to improve acquisi-
tion of neural rosettes structures at depths greater than 
500 µm deep within hCSs. Specifically, we imaged intact 
hCSs generated from hiPSCs, using an Airy-beam light 
sheet microscopy (ALSM) system [27], in combination 
with an optimized immunohistochemical protocol based 
on the Fast free-of-acrylamide clearing tissue (FACT) 
methodology [32] and a refractive index (RI)-matched 
fast tissue clearing approach based on the ScaleS [31]. We 
confirm that the ALSM is superior in imaging through 
intact, non-clarified, in  vitro tissues, both in speed and 
resolution as compared to conventional confocal imaging 
systems. Furthermore, optimised immunohistochemistry 
and clearing of hCSs allowed for enhanced visualisation 
of internal structures. This enabled the visualisation of 
the inner lumen of neural rosettes in 3D and indicated 
that these structures may develop as a polarised tube-
like structure. These finding indicate that ALSM imaging 
in combination with optimized immunohistochemistry 
and tissue clearing promises to yield significantly better 
3D imaging of internal structures in brain organoids and 
thus will facilitate the study of neurodevelopmental pro-
cesses relevant for typical and atypical development.
Results
Application of Airy‑beam light sheet microscopy (ALSM) 
with high resolution
A particular advantage of ALSM is that it has a wider 
field of view (FOV) than Gaussian or Bessel-based light 
sheet beams due to the properties of the propagation-
invariant Airy beam [27] (Fig. 1a–c). This in-turn means 
that the high axial resolution is maintained across that 
FOV without the need for compromising the FOV or res-
olution, unlike other light sheet systems. The Airy-beam 
delivers a field of view 20 times larger than a Gaussian 
beam and 8 times larger than a Bessel beam equipped on 
the same system [27]. The Airy-beam also provides an 
axial resolution comparable to that of the Gaussian and 
twice as good as the Bessel beam [27]. The Airy-beam’s 
characteristic asymmetric excitation pattern creates 
lobes spreading the beam across the FOV, lowering the 
overall light exposure to the sample resulting in 80% less 
photo-bleaching in comparison with the Gaussian beam 
[27]. Furthermore, it only requires a single exposure per 
z slice compared to the multiple acquisitions required for 
some light sheet approaches such as dual inverted selec-
tive plane illumination microscopy, further reducing 
(See figure on next page.)
Fig. 1 Setup and resolution of Airy‑beam light sheet microscopy (ALSM). a ALSM system is equipped with 2 water dipping objectives—10 × 0.3 
NA illumination and 20X 0.5 NA detection objective—positioned at a 45° angle. Biological specimens are placed on the X‑Y‑Z stage. Movement of 
the stage is controlled by a Z‑axis Stepper motor (ZSM) which moves the sample along the optical axis of the detection objective. The system is 
equipped with 405 nm, 488 nm, 561 nm and 640 nm wavelength lasers. b Illumination objective focuses the Airy‑beam (green) on to sample and 
the detection objective captures the emission (yellow) at 90 degrees. The geometry of the objectives gives the system a (hypothetical) working 
distance of 3.5 mm. c An example of the Airy‑beam produced by focusing the 488 nm laser though water. d Representative image of a 500 nm 
Tetraspeck fluorescent beads imaged at 405, 488, 561 and 640 wavelengths; image has not undergone deconvolution. Characteristic Airy lobes 
can be seen in the axial plane. e Deconvolved image of the fluorescent bead in C). Axial Airy lobes have been removed following deconvolution. f 
Image of a single 500 nm Tetraspeck fluorescent bead; the PSF of a single 500 nm bead is 0.625 μm diameter at full width at half maximum (FWHM) 
when imaged at 488 nm. Scale bars = 500 nm unless stated otherwise
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photo-toxicity [27]. Thus, using an exposure time of 
50 ms (ms), the acquisitions of a 1500 slice stack would 
take 75  s per channel. The ALSM system uses 2 water 
dipping objectives. The geometry of the objectives means 
the maximum sample area the light sheet can image is 
approximately 3.5 mm in depth (XZ axis) and 3.5 mm in 
width (X axis), but along the y-axis it is possible to have 
a dimension larger than 3.5  mm (Fig.  1a, b). However, 
due to the physical dimensions of the space in between 
the lenses and the need to move the sample around to 
acquire an image, the actual FOV is 600 × 600 × 600 µm.
The resolution of the ALSM system used in this study 
was determined by measuring 500  nm sub-resolution 
Tetraspeck fluorescent beads at multiple wavelengths. 
Raw (pre-deconvolution) image acquisition of beads 
resulted in a data stack that upon re-slicing displayed 
Airy lobes artefacts in the axial plane (Fig. 1d). All bead 
stacks were subsequently deconvolved [27] using an 
extracted bead PSF and processed using Richardson–
Lucy deconvolution (MSquared Cubes software). This 
restored the image, increasing the signal-to-noise and 
removed the geometric curvature of the Airy-beam 
(Fig.  1e). Measurements of resolution was assessed by 
determining the “Full width at half maximum” (FWHM) 
at the 488  nm wavelength of resliced beads where the 
mean system has a resolution of 0.625 µm (Fig. 1f ).
Challenges associated with imaging of hCSs using confocal 
microscopy
In order for us to assess the utility of ALSM for the imag-
ing of 3D organoid cultures, we differentiated 3 well 
characterised hiPSC lines from our group [12, 15] using 
a free-floating directed culture method to generate 3D 
cortical spheroids (hCSs) [2] (Additional file  1: Fig-
ure 1A-E). At day 7, hCS specimens were ~ 100–300 μm 
in size (Additional file 1: Figure 1C). Cryo-sectioning of 
day 7 hCS often resulted in tissue damage. Therefore, 
day 7 hCSs were imaged as ‘wholemount’ intact samples 
by conventional confocal microscopy. As expected hCS 
generated from hiPSCs demonstrated the key hallmarks 
of in vitro cortical differentiation [2, 6, 16]. At this time 
point, hCSs were positive for the early neuroepithelium 
markers Nestin and Sox2 (Fig. 2a). These spheroids also 
displayed N-cadherin-positive membranes (Fig.  2b), 
indicative of the emergence of neural rosettes [6, 16]. In 
addition, hCSs were generally positive for Pax6, reinforc-
ing the fate specification of a cortical neural progenitor 
cell (NPC) population (Fig. 2b).
Although confocal microscopy was easily able to 
acquire z-stack images of superficial regions of hCSs, 
it was insufficient to acquire images of the entire sphe-
roids. On average, we were only able to image up to 
50–100 μm deep into hCS before significant signal drop-
off occurred. This is demonstrated in Fig.  2c where we 
have imaged a day 7 hCS of approximately 300  µm in 
diameter, stained for DAPI, Nestin and Sox2. Confo-
cal images were acquired as a z-stack—images were 
acquired every 20  µm (1z step depth = 0.4  µm, using a 
63 × NA1.4 oil immersion objective) resulting in a total 
imaged depth of 280 µm (Additional  file 1: Figure 2A-C). 
In all 3 channels, fluorescent signal towards the centre of 
the hCS tissue weakened dramatically at greater depth 
(> 100 µm), as demonstrated by intensity profiles for each 
channel through the z-plane (Fig. 2c, d; Additional file 1: 
Figure  2D). This indicated either a poor acquisition of 
fluorescent signal via confocal acquisition or a failure of 
antibodies to fully permeate the tissue during prepara-
tion. However, fluorescent signal was similarly weakened 
beyond 100  µm in the DAPI channel, which is a highly 
penetrant small molecule fluorescent stain for DNA 
(Fig.  2c, d; Additional file  1: Figure  2D). This indicated 
that confocal microscopy was unable to image internal 
structures within intact spheroids.
We next characterised day 17 hCS, which were con-
siderably larger than day 7 hCS. As day 17 hCSs ranged 
between 800 and 1200 μm in diameter (Additional file 1: 
Figure  1C), it was not possible to image intact day 17 
spheroids using confocal microscopy. Consequently, day 
17 hCSs were prepared as 20 or 60  μm cryo-sections 
before immunostaining and subsequent imaging with by 
confocal microscopy. Imaging of thin (20 µm) day 17 hCS 
cryo-sections demonstrated the expected neural rosette 
organisation of axial polarity with a lumen delineated by 
adjoining neural progenitor cells (Fig.  3a–d). The inner 
lumen of neural rosettes was highlighted by the presence 
of tight junction proteins ZO-1 and N-cadherin (N-cad), 
Fig. 2 Confocal imaging of wholemount day 7 human cortical spheroids (hCSs) is limited at depth. a Representative confocal images of intact 
(wholemount) day 7 hCS showing strong immunostaining for the neuroepithelial/NPC markers Nestin and Sox2. b Representative confocal image 
of wholemount day 7 hCS demonstrates hallmarks of the emergence of neural rosettes, as determined by N‑cadherin (N‑cad) staining of apical 
membrane and surrounding Pax6‑positive cells. c Maximally projected and orthogonal views of Z stacks of intact Day 7 hCSs acquired by confocal 
imaging. Confocal imaging displays a drop‑off in fluorescence intensity correlated with acquisition depth (Z planes). (i) DAPI, a non‑antibody stain 
for DNA shows incomplete detection throughout the tissue‑like structure. Similarly, (ii) Nestin‑positive and (iii) Sox2‑positive immunostaining 
displays even greater drop off in depth‑detection, shown in (iii) as a fluorescence‑intensity heatmap. d Graphic depicting changes in fluorescent 
intensity (A.U.) with increasing imaging depth (μm) of Ci–iii. Scale bars = 50 μm
(See figure on next page.)
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as well as PKCλ-positive cells, indicating maintenance 
of adherent junctions by neural progenitors (Fig.  3a–c). 
In the region immediately surrounding the inner lumen, 
nestin- and Pax6-positive cells were radially organised as 
expected for early NPCs (Fig. 3a, b). Consistent with our 
recent study [12], hCSs generated from autism hiPSCs 
displayed aberrant neural rosette formation, as demon-
strated by incomplete ZO-1 apical membrane formation 
(Additional file  1: Figure  3B). Furthermore, the radial 
organisation of Pax6-positive NPCs around ZO-1-posi-
tive lumens was disrupted in autism hCSs compared to 
control hCSs (Additional file  1: Figure  3A and B). DCX 
and MAP2-positive cells representative of the differen-
tiation of NPCs into newborn and immature neuronal 
cells could be seen constituting the outer layers of the 
neural rosette (Fig. 3c, d). Overall, the description of neu-
ral rosette organisation and structure was similar to that 
previously described in 3D studies [2, 6, 16].
Interestingly, imaging of thicker sections (60 µm) occa-
sionally revealed further insight into the emergence of 
rosette structures as well as greater detail on the potential 
morphology of the rosette lumen. For example, PKCλ, a 
putative organisational marker of neural rosettes, could at 
times be seen in pinched groups of cells at the outer layer 
of tissue (Fig.  3e; yellow arrows). These PKCλ-positive 
cells are thought to represent cells that internalise to sub-
sequently form the inner lumen of rosettes [16, 35] In 
addition, when we imaged thick (60 µm) sections stained 
for N-cadherin, we were able to occasionally observe 
rosette lumens as uneven, elongated or tubular structures 
(Fig. 3f ). This raised the possibility that the inner lumen 
of neural rosettes develops a tube-like morphology when 
spatially un-restricted in 3D and that we had serendipi-
tously sectioned laterally through the inner lumen of a 
rosette (Fig.  3f; cyan arrow). A similar morphology was 
also observed in hCS sections stained for F-actin using 
an AlexaFluor 488-conjugated phalloidin stain (Actin-
Green™ 488 ReadyProbes™—referred to as RDYPROBE). 
RDYPROBE staining of F-actin, a major cytoskeletal 
component, was concentrated around the inner lumen of 
neural rosettes (Fig.  3g; cyan arrow) similar to previous 
reports [16, 18]. However, F-actin staining could also be 
seen as polarised tube-like structures (Fig.  3g; magenta 
arrows) similar to that seen with N-cadherin staining. 
Taken together, these data indicate that rosette lumens 
may develop into tube-like structures when grown in 3D, 
and that cryo-sectioning followed by confocal imaging 
is not sufficient to fully capture the morphology of these 
structures in sectioned spheroids.
ALSM imaging of intact hCS
Having established that confocal microscopy was limited 
to imaging ~ 100 µm deep into intact spheroids, we next 
tested the ability of ALSM to image at greater depths. 
To this end, we generated day 30 hCSs and stained them 
with RDYPROBE to label F-actin, and thus the structure 
of neural rosettes. An ALSM image of a day 30 hCSs 
(diameter =  ~ 1.2  mm) was acquired as a single z-stack. 
A raw output max intensity Z-projection (z-stack = 500 
images—600 × 600 × 200  µm) can been seen in Addi-
tional l file 1: Figure 4Ai (Raw image). This image stack 
subsequently underwent deconvolution using a Rich-
ardson–Lucy algorithm [36, 37] specific to the ALSM 
(MSquared Cubes software). Following this image pro-
cessing, multiple neural rosettes with tube-like structures 
could be observed within the hCS (Additional file 1: Fig-
ure 4Aii—Deconvolved Image). However, we noted that 
some non-specific staining on the surface appeared very 
bright leading to features of interest appearing dimmer. 
Therefore, we removed the images of the outer layer of 
tissues from the 3D image stack. This removed highly 
stained cells at the edge which had a higher fluorescence 
than internal structures and thus allowed for a clearer 
visualisation of internal rosettes (Additional file  1: Fig-
ure  4B). Multiple neural rosette lumens with different 
shapes and sizes could be observed in both 3D renders 
and max projection images (Fig.  4a, b). Larger rounder 
rosette lumens were observed towards the middle of the 
tissue, whereas smaller extended tube-like rosettes can 
be found towards the edge of the tissue (Fig. 4a, b). These 
structures had diameters ranging between 20–50  µm, 
and lengths between 20–200 µm.
We next imaged a day 30 hCS that was stained with 
RDYPROBE and immunostained with the NPC marker 
(See figure on next page.)
Fig. 3 Confocal imaging of cryo‑sectioned day 17 hCSs reveals incomplete acquisition of neural rosette 3D morphology. a–d Representative 
confocal images of sectioned (20 µm) day 17 hCSs; a ZO‑1 staining of apical membrane is surrounded by apico‑basal polarised Nestin filaments; 
b Pax6‑positive cells self‑organise around N‑cad positive foci; c Immature DCX‑positive neuronal processes are found outside of neural rosette 
structures; and d Map2‑positive neuronal processes are also found to surround Pax6‑positive NPCs organised into rosettes. e Confocal imaging of 
60 μm sectioned day 17 hCSs express signs of cortical rosette formation. Newly formed PKCλ‑positive membranes are seen at the edge of the tissue 
as indicated by yellow arrows. f Within thicker sections (60 μm), internalised tubular structures positive for N‑cad are observed, suggesting that 
the inner lumen of neural rosettes may form into tube‑like structures. g Phalloidin 488‑positive actin filaments (RDYPROBE) show a concentrated 
organisation around ventricle‑like structures. Magenta arrows in e–g images highlight the ovoid formation of cortical rosettes with a pinched end, 
whereas blue arrows highlight formation of a tubular‑like structure. Scale bars = 100 µm (a–d); 50 μm (e–g)
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Nestin to assess signal intensity deep within day 30 hCSs 
(Fig.  4c and Additional file  1: Figure  4C). As expected, 
F-actin staining revealed several neural rosette lumens 
within the spheroid. High magnification zoom-ins of 
F-actin enriched apical membrane showed that Nestin-
positive cells were organised radially around the central 
lumen (Fig.  4c) with Nestin filaments being polarised 
and projecting away from the central lumen (Fig.  4c). 
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However, examination of individual channels revealed 
differences in signal intensity and image clarity at depth 
(Fig.  4c–e). F-actin staining could be seen though most 
of the spheroid (Fig. 4c, d; Additional file 1: Figure 4D), 
with signal intensity dropping when reaching the inner 
most regions of the spheroid. Similarly, the signal inten-
sity from Nestin staining substantially dropped at more 
superficial depths compared to the F-actin stain, with 
a loss of resolution at depth towards the centre of the 
imaged hCS (Fig.  4d, e). Thus, visualisation of the co-
localisation of Nestin-positive cells and F-actin associ-
ated filaments around the apical domain of the rosette 
lumen was limited at depth (> 200  µm). Despite this, 
orthogonal examination displayed ALSM maintains a 
much greater resolution and clarity compared to confo-
cal when imaging at depth (Fig. 4e). Together, these data 
demonstrate that the ALSM can rapidly acquire multi-
channel 3D volumes, but with limited resolution when 
imaging hCS at depth.
Optimised immunohistochemistry and tissue clearing 
improves ALSM imaging of deep structures within hCS
Studies have shown that effective imaging at depth can 
be enhanced by clearing the 3D tissue and optimising 
immunostaining protocols before LSM imaging [25, 38, 
39]. As our day 30 spheroids were approximately 2 mm in 
diameter (Additional file 1: Figure 1E), we reasoned that 
optimizing our immunostaining protocol would improve 
antibody penetration in 3D tissue as previously described 
[32]. As, it is well understood that lipids cause light scat-
tering which interfere with deep tissue imaging, we fur-
ther reasoned that cleared our hCSs so that the lipids 
were replaced with a clear water-soluble matrix, would 
reduce light scattering and therefore improve fluores-
cent signal within spheroids [31, 32]. Optimised immu-
nostaining was achieved by using glycine and DMSO at 
low concentrations which improve pH and antibody sta-
bility for longer incubation periods, while using Tween-
20 to help make cells more porous for better antibody 
penetration [32]. Next, hCSs underwent tissue clearing 
using the ScaleS4 method, a rapid aqueous-based tissue 
clearing approach that which takes 4 h [31].
Fig. 4 Visualising internal structures of hCSs using Airy‑beam light sheet fluorescent microscopy. a Clearvolume 3D representation of multiple 
internalised rosette lumen of differing sizes shown by RDYPROBE staining (F‑actin) with dimensional scale. b Magnified region (a, dotted line) 
showing characteristic ovoid or tubular shaped lumens expected of a ventricle‑like structure. c Composite (i) and individual channel max‑projected 
images of (ii) RDYPROBE (F‑actin) staining and (iii) Nestin‑positive filaments around apical membranes, showing the presence of multiple large 
rosettes, Scale bars = 100 μm. d 3D render of magnified region from ci (dotted line) displaying of a singular rosette lumen co‑stained for radial 
Nestin filaments and RDYPROBE (F‑actin) with dimensional scale. e Orthogonal views of stained tissues permit examination of a cortical rosette in all 
axes. Scale bar = 50 μm
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Cleared hCSs were immunostained with Sox2 (NPC 
marker) and ZO-1 as a marker of the apical membrane of 
rosettes (Additional file 1: Figure 5A). Unlike non-cleared 
hCSs, antibody signal could be detected throughout the 
600 × 600 × 600  µm captured image without any obvious 
loss of fluorescent signal (Fig. 5a–c; Additional file 1: Fig-
ure 5B and Additional file 2: Movie 1). Both ZO-1 positive 
apical membranes as well as Sox2-positive cells could be 
easily detected in optical sections at various levels within 
the 1501 image z-stack (Additional file 1: Figure 5B). Each 
image was acquired with a 50  ms exposure time; thus, 
the acquisition of a 1501 slice stack took 75  s per chan-
nel. It is of note that several ‘cones’ of bright signal could 
be observed at the peripheral of the images (Fig. 5a; white 
asterisks). This is likely due to saturation of the detector 
due to fluorophore crystal/condensates creating artefacts 
after deconvolution. In 3D renders of the imaged volume 
(Fig.  5b), both ZO-1 and Sox2 could be seen at different 
depth within the spheroid (Fig.  5c and Additional file  2: 
Video 1). Consistent with expected results, Sox2-positive 
cells were organised in a radial manner around ZO-1 posi-
tive rosette lumens (Fig.  5c; Additional file  1: Figure  5B). 
Together these data indicate that the combination of an 
optimised immunostaining protocol with an aqueous 
clearing method vastly improves imaging depth in hCS.
ALSM imaging of hCS reveals 3D morphology of neural 
rosette inner lumen
Confocal imaging of sectioned day 17 hCS indicated that 
the inner lumen of neural rosettes may develop large spher-
ical or tubular lumens (Fig. 3c–e). However, it was not pos-
sible to gain an understanding of the 3D morphology of 
the central lumen or surrounding cells by confocal micros-
copy due to signal-to-noise limitations at greater depths 
(> 100 µm) (Additional file 1: Figure 2). Conversely, ALSM 
imaging of day 30 hCS stained with ZO-1 (Fig.  5) indi-
cated that it may be possible to visualise the intact inner 
lumen of a rosette. To this end, we generated 3D renders 
of the ZO-1 channel from ALSM imaged day 30 cleared 
hCSs. Multiple ZO-1 positive structures could be detected 
within a single hCS (Fig. 6a). Morphological measurements 
of ZO-1-positive rosette lumens revealed that they varied 
in size and volume (Fig. 6a, b)—only structures with a vol-
ume of > 150 µm3 were considered as true rosette lumens 
[16] and included in morphological analyses (Fig.  6c–f). 
Most ZO-1-positive lumens (> 95%) had volumes ranging 
between ~ 150 to < 10,000  µm3: 75% of measured lumens 
were less than 1000 µm3 (Fig. 6c), and a surface area that 
ranged between ~ 200 to > 10,000 µm2; again the majority of 
lumens (~ 66%) were less than 1000 µm2 (Fig. 6d). A sin-
gle large rosette lumen could be readily observed (Fig. 6g, 
h; Additional file 1: Figure 6A & B). This structure had vol-
ume of 192,484.21 µm3 and corresponding surface area of 
146,697.61  µm2. It was also possible to extract additional 
morphological parameters including length at the longest 
axis and shape factor, a measure of sphericity (Fig. 6e, f ). 
Finally, by focusing on a single large rosette lumen, it was 
possible to gain an appreciation of the radial organisa-
tion of Sox2-positive NPCs surrounding the inner lumen 
of rosettes in 3D (Fig. 6i; Additional file 1: Figure 6C and 
Additional file 3: Movie 2). Taken together, these data dem-
onstrate that following an optimised immunohistochemi-
cal and tissue clearing approach, that it is possible to gain 
insights into the 3D structure and organisation of neural 
rosettes and surrounding NPCs in hCSs.
Discussion
The ability to generate 3D brain organoids from somatic 
cell-derived human hiPSC is a great tool to further our 
understanding of human brain development in health and 
disease [2–4, 6, 7, 17]. Multiple lines of evidence indicate 
prenatal development as a critical period for the emergence 
of cellular differences that may contribute to the emergence 
of autism [8]. Studies using patient derived hiPSCs grown 
as either 2D adherent cultures or as 3D organoids have fur-
ther supported such findings [9–12]. To date, most studies 
utilizing 3D organoids have relied on conventional tissue 
processing and imaging modalities that are not optimized 
for the preservation and imaging of intact organoids [25, 
28]. This result in the loss of the significance and under-
standing of the cellular processes, organisation and com-
plexity within a three-dimensional environment [25]. Here, 
we have optimized an immunohistochemical and tissue 
clearing approach in combination with ALSM imaging that 
enables rapid and high resolution imaging of intact hCS. 
Using this approach, we were able to visualise and quantify 
the three-dimensional cellular structure of the inner lumen 
of neural rosettes. This structure is described as an in vitro 
correlate of the human neural tube which begins to form 
at gestational week 4 and is the source of the entire central 
nervous system [16]. As the formation or maintenance of 
structure of neural rosettes has been reported to be altered 
(See figure on next page.)
Fig. 5 ALSM imaging of cleared hCSs. a Representative 3D volume image (600 × 600 × 600 µm) of cleared day 30 hCS immunostained with 
ZO‑1 (green) and Sox2 (magenta) and imaged by ALSM. b Schematic image of ALSM optical sections of cleared hCS shown in c. c ALSM optical 
Sects. (600 × 600 × 50 µm) at 450, 500 and 550 µm depth, of cleared hCS shown in a. Cyan arrows indicate ZO‑1‑positive rosette lumen with 
surrounding radially organised Sox2‑positive NPCs. Green and red bars indicate scale in X and Y planes (600 µm)—blue scale bar indicates scale in Z 
plane (600 µm in a and 50 µm in c)
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in autism and related neurodevelopmental disorders [8, 
12, 40], being able to examine the cellular organisation and 
morphology of neural rosettes in 3D may offer insight into 
pathological mechanisms that contribute to the likelihood 
of developing such disorders.
Conventional methods to study brain organoids such as 
hCS are often hampered by a number of limitations such 
as the inability to acquire images of cellular structures 
and organisation within intact specimens. For example, 
we found that even imaging of intact hCS with a diam-
eter of ~ 300  µm resulted in a rapid loss of fluorescence 
signal approximately 100 µm into the tissue. This was not 
due to an issue of antibody penetration as the observed 
signal loss was also observed when imaging DAPI, a non-
antibody stain. We were able to overcome this limitation 
by using an ALSM imaging modality coupled with opti-
cal tissue clearing and optimized immunohistochem-
istry. Advantages of using this form of LSM include the 
ability to rapidly acquire images in a large volume and a 
large FOV [27]. This allowed visualization of the inner 
lumen of neural rosettes in 3D in a manner not possible 
using confocal microscopy. Using the F-actin stain RDY-
PROBE, we observed ovoid- or tubular-shaped lumens 
of neural rosettes. It was also possible to observed radial 
arrangement of NPCs cells around the lumens. This was 
our first evidence of the 3D shape of neural rosettes and 
surrounding NPCs.
Despite this improved ability to image neural rosettes 
within intact hCSs, a loss of signal was still evident at 
depth, albeit much less that than observed following con-
focal imaging. It is well recognised that the presence of 
lipids within tissue samples causes a scattering of light 
and therefore impedes effective volume imaging [25, 29, 
31, 38]. In addition, uneven, or incomplete penetrance of 
antibodies could also contribute to this issue [32]. Our 
approach to address the issue of uneven or incomplete 
antibody penetration was to use the optimized immu-
nostaining approach described in the FACT clearing 
protocol [32]. However, in this protocol, tissue clearing 
takes 1  week followed by 4  days for antibody staining. 
Fig. 6 Visualisation and quantification of neural rosette lumen morphology in intact cleared hCSs. a Representative 3D volume images of 
ZO‑1‑positive apical lumen membranes of cleared day 30 hCS. b Rosette lumens were defined as objects in Volocity (PerkinElmer) by thresholding 
volumetric regions based on ZO‑1 channel. Objects with volumes of less than 150 µm3 were discarded. c, d Frequency distribution of neural 
rosette lumen volume (µm3; c) and surface area (µm2; d). Measurements of these morphological parameters revealed a single neural rosette with 
a lumen with a volume of 192,484.21 µm3 and surface area of 146,697.61 µm2. e, f Frequency distribution of neural rosette lumen length (µm; e) 
and shape factor f, g Digital zoom of largest neural rosette lumen. Green channel indicates ZO‑1‑positive apical membrane; magenta channel 
indicates Sox2‑positive NPCs surrounding central lumen. h Threshold image of ZO‑1‑positive lumen demonstrating morphology of structure in 3D. 
i Representative 3D render of largest neural rosette lumen demonstrating the radial organisation of Sox2‑positive NPCs surrounding ZO‑1‑positive 
(green) rosette lumen
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In order to shorten this duration, we used the optimised 
immunostaining protocol in FACT (4  days) in conjunc-
tion with a more efficient and quick clearing method, 
ScaleS4 which takes 4 h [31]. By combining this approach 
with ScaleS4 clearing, our tissue preparation time was 
reduced to less than half (~ 5  days) of the FACT proto-
col. This is also much less compared to other established 
protocols such as CLARITY (~ 20  days) and CUBIC 
(~ 11 days) [29, 31, 32]. As FACT and ScaleS4 were both 
aqueous-based protocols, we found they were quite com-
patible when used together. This optimized tissue clear-
ing approach further improved ALSM imaging of intact 
hCS. This allowed us to visualise the inner lumen and the 
radial organisation of the NPCs surrounding the inner 
domain of the rosette, and thus providing a representa-
tion of the 3D structure of the neural rosette. This is of 
particular interest as our previous studies indicate that 
abnormal neural rosette formation is apparent in autism 
hiPSCs differentiated either in 2D adherent cultures or 
in 3D hCSs [12] (Additional file 1: Figure 3). Importantly, 
the observed radial arrangement of NPCs around the 
inner lumen of rosettes is consistent with the organisa-
tion of DAPI-stained cells around a central lumen of 
intact embryoid bodies generated from hiPSCs and sub-
sequently cleared and imaged using a new single-objec-
tive planar-illumination two-photon microscope [28]. A 
notable difference in the system described by Rakotoson 
et  al. is that their system uses a two-photon laser. Such 
a microscope is also optimised for fast imaging, affords 
less photobleaching and permits better depth penetra-
tion compared to confocal microscopes [28], similar to 
the ALSM system utilised in this study. We anticipate 
that two-photon microscopy in general would enable 
deeper penetration due to the infra-red wavelengths not 
being absorbed by the tissue. Of note, we have recently 
described a two-photon ALSM system that is also opti-
mised for fast two-photon imaging at depth [41]. A com-
parison of both systems, especially in live specimens 
where fast imaging is desirable, would be of interest in 
the future. Nevertheless, to our knowledge, this is one 
of the first studies to demonstrate the ability to visual-
ise the lumen and arrangement of NPCs surrounding 
neural rosettes in 3D. From the cleared images of neural 
rosettes, we were able to clearly delineate the edges of the 
lumen and create a 3D reconstruction of the shape of the 
lumen. This allowed us to quantify the size of the lumens 
and found that most lumens in a given spheroid had vol-
umes less than 1000 µm3, while only few had volumes 
larger than 10,000 µm3.
The presence of a single neural rosette with a large 
lumen is similar to that previously reported [16]. The 
formation of a single large rosette is considered an essen-
tial feature of normal brain development and critical 
for establishing typical tissue cytoarchitecture and nor-
mal differentiation of neuroepithelial cells during brain 
development [16]. Consistent with this, it was possible 
to observe the radial organisation of NPCs around the 
large rosette in 3D [2, 5–7]. Thus, this approach suggests 
that it is possible to examine typical cellular maturation 
observed in neurodevelopment in 3D. Thus, this com-
bined approach would be a good cellular model to study 
neurodevelopmental conditions such as autism.
Limitations
The ALSM system used in this study has a working dis-
tance of 3.5  mm due to the physical room between the 
illumination and detection objectives. Furthermore, 
while a day 7 hCS could fit fully into the FOV, only a 
part of the day 30 tissues (600 × 600 × 600 μm) could be 
imaged. A number of alternative forms of LSMs have 
been developed that could be used as an alternative [25, 
42]. Despite these limits, a rapid acquisition time (~ 75 s 
for 1501 z-slices per channel) allows for quick reposition-
ing of tissues to new fields of view or different ranges of 
depth.
In this study, we have generated hCS brain organoids as 
an in vitro model of cortical development. However, this 
protocol is variable, often producing organoids of various 
sizes, and moreover, only generates cells representative 
of the dorsal forebrain. A number of protocols have been 
described for the generation of 3D brain organoids with 
less variability and of different brain regions in addition 
to the generation of ‘fused’ organoids that model multi-
ple brain regions [1–3, 22–24]. Such approaches could be 
used to reduce variability and would facilitate the model-
ling and examination of cellular organisation, process and 
interaction between multiple brain regions.
The key problem being faced by the field of volumetric 
acquisition (including the use of ScaleS or CLARITY) is 
the need for standardised methods of volumetric quanti-
fication, in order to fully extrapolate the vastly powerful 
data obtained [25, 29, 33, 42]. Due to current popularity 
of 2D cell culture and sectioned tissues, many means of 
quantification disregard the possibility of a third spatial 
dimension. However, a number of programs, includ-
ing open-source programs, which include high-through 
acquisition and automated quantification of 3D struc-
tures are being developed [42–44].
Conclusion
In summary, the combined optimised immunohis-
tochemical, optical tissue clearing and ALSM imag-
ing approach described here represents an alternative 
method to image intact hCSs compared to conventional 
tissue processing and imaging modalities. Using this 
approach, it is possible to visualise cellular structures 
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critical to human brain development in the hCS in vitro 
model in 3D. From imaging 3D spheroids, we have 
observed the ovoid, tubular structure of the lumens, 
and the radial arrangement of differentiating neural pro-
genitor cells within the neural rosette. We also observed 
larger neural rosettes were fewer in number in a sphe-
roid, approaching the singularity that is observed in vivo 
during neural tube formation. This was evidence that 
this method could be used to study typical human brain 
development, and characteristics of neural rosette forma-
tion could be used to study brain development in neu-
rodevelopmental conditions such as autism.
Methods
Study aim and design
The aims of this study encompassed two core objectives: 
(1) comparison of conventional tissue processing and 
image acquisition methods against a novel methodol-
ogy of presenting intact 3D tissue for volumetric acqui-
sition using an ALSM; and (2) to determine whether 
clarification of tissue would improve acquisition of neu-
ral rosettes deep within hCSs. To this end, hCSs were 
differentiated from 3 previously well characterise hiP-
SCs [15]—CTR_M1; CTR_M2 and CTR_M3—up to 2 
clones per line were utilized in the study. For all experi-
ments, hCSs were generated from each line (1–2 clones); 
images presented in figures are representative of struc-
tures observed from all lines. Between 2 and 5 independ-
ent batches of hCS were generated for each experiment 
where a batch was defined as an independent differentia-
tion from hiPSCs.
HiPSC maintenance
HiPSCs from 3 typically developing individuals (CTR_
M1; CTR_M2 and CTR_M3) were generated as previ-
ously described as part of EU-AIMS and STEMBANCC 
EU IMIs [12, 15]. Ethical approval for the generation of 
hiPSCs was approved under the PiNDS study (REC: 13/
LO/1218). HiPSCs were grown and maintained in E8 
medium (Life Technologies) with E8 supplement (Life 
Technologies). HiPSCs were passaged by first dissociat-
ing attached cells from the plate, by incubating them 
in Versene (Thermo Fisher) for 4–5  min in 37  °C incu-
bator. Versene helps gently lift edges of iPSC colonies, 
after which it was replaced with E8 and cells were lifted 
using a cell lifter. Free-floating cells were re-plated onto 
fresh geltrex-coated (Thermo Fisher) plates. For main-
tenance, cells were re-plated at ~ 70% confluency. For 
starting a new experiment, cells were re-plated at ~ 100% 
confluency.
Generation of human cortical spheroids
HiPSCs were differentiated into human cortical sphe-
roids (hCS) using methods published by Pasca et  al. 
In this method, dual SMAD inhibition was performed 
using KOSR media supplemented with 10  µM ROCKi 
and SMAD inhibitors: 5  µM dorsomorphin (Tocris) 
and 10 µM SB431542 (Tocris) to direct hiPSCs towards 
a cortical lineage. Cultures were maintained in 5% CO2 
at 37  °C for 48-h period to promote formation of sphe-
roids. From day 2 until day 4, media changes were per-
formed daily with fresh KOSR media supplemented with 
5  µM dorsomorphin and 10  µM SB431542. From day 5 
until day 25 (or when hCSs were harvested), culture 
media used was B27 minus Vitamin A (Life Technolo-
gies) media plus 20  ng/mL of recombinant human EGF 
and recombinant human bFGF (both Preprotech). From 
day 25, B27 minus Vitamin A media with 20  ng/mL of 
recombinant human BDNF (Preprotech) and recombi-
nant human NT3 (LifeTechnologies) was used. Media 
was changed every 24 h during the first 15 days and once 
every 48 h thereafter. Spheroids were harvested at days 7, 
17 or 30.
Sample preparation for confocal microscopy
Cortical Spheroids harvested at Day 7 were fixed in 4% 
formaldehyde in 4% sucrose/PBS for 45 min then washed 
three times with PBS. Once fixed, spheroids were per-
meabilised in 0.3% Triton X100/PBS for 30  min, before 
permeabilisation-blocking for an hour in 2% NGS in 0.3% 
Triton X100/PBS. Subsequently spheroids were incu-
bated in a solution containing 1° antibodies, 2% NGS 
and 0.1% Triton X100/PBS at 4  °C for a 48-h period. 
Spheroids were then washed three times in PBS before 
being incubated overnight in a solution of 2° antibodies, 
2% NGS and 0.1% Triton X100/PBS in a lightproof con-
tainer at 4  °C. Post-incubation spheroids were washed 
twice in PBS before DAPI stain was applied. Prepared 
samples were mounted intact onto Superfrost plus slides 
(VWR, 631-0108P) by suspending in Mowiol mounting 
media (Sigma Aldrich, 81381) and surrounding with sili-
con grease (to protect tissue from high pressures) before 
applying glass coverslips (VWR, 631-1574) and leaving 
for 48 h to set (Fig. 6b). Prior to imaging using confocal 
microscopy, slides were stored at 4 °C in the dark. Sphe-
roids harvested at Day 17 were fixed in 4% formaldehyde/
PBS for 1 h, followed by three PBS washes before incuba-
tion in 30% sucrose solution (weight/volume) overnight. 
Once spheroids had normalised, they were placed into 
moulds and cryopreserved in OCT or M1 freezing media 
via snap-freezing on dry ice, before storage at − 80  °C. 
Cryopreserved tissues were cryosectioned using a Leica 
CM1850 cryostat at 20  μm, 40  μm and 60  μm section 
depth prior to mounting on Superfrost plus slides for 
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fluorescent immunohistochemistry. Sample slides were 
treated via the same process as post-fix 2D cell culture 
coverslips, before being mounted with Mowiol and a 
glass coverslip. Prepared slides were stored in darkness 
at 4 °C, before image acquisition via confocal microscopy. 
Compared to Day 7, Day 30 spheroids were significantly 
larger (Fig. 5c and 5e) and thus required longer treatment 
to ensure penetrance of washes into deep tissue. Day 30 
spheroids were fixed in 4% formaldehyde/PBS for 2  h, 
followed by rinsing with three PBS washes, before a per-
meabilisation-blocking step of 10% NGS in 0.3% Triton 
X100/PBS for 1 h 30 min. Permeabilised spheroids were 
incubated for 48 h at 4 °C in a 1° solution, consisting of 1° 
antibodies in 10% NGS and 0.1% Triton X100/PBS. Sub-
sequently spheroids were washed three times with PBS 
and incubated in a 2° solution consisting of 2° antibodies 
in 10% NGS and 0.1% Triton X100/PBS overnight at 4 °C, 
protected from light. Stained spheroids were washed 
thrice in PBS before being transferred to 0.02% NaN3/
PBS for long-term storage to prevent microbial growth 
and tissue degradation. Once ready for imaging, tissues 
were immersed in ~ 50 °C 0.1% low melting point agarose 
and set onto specialised mounting slides for light sheet 
acquisition (Fig. 6c). Tissues could be reclaimable by dis-
integrating the agarose-matrix bead in PBS with time, 
thus permitting reimaging.
Permeabilised samples were incubated in solution, 
consisting of primary antibodies (Additional file  1: 
Table  1). Superfrost plus slides using Prolong Gold 
mounting media (Thermo Fisher, P36934) were used to 
reduce photo-bleaching of fluorophores and left in dark-
ness at RT overnight to set, before imaging via confocal 
microscopy.
Sample preparation for ALSM imaging of intact hCS
Non‑cleared spheroids
The hCS  were first washed in PBS for 3  min and then 
fixed in 4% formaldehyde in 4% sucrose-PBS. The fixation 
time was 45  min for day 30 spheroids. Once the sphe-
roids were fixed, they were washed again in for 3  min 
(3 times) in PBS and stored in sucrose 30% (weight/
volume) the sucrose sinking improves their preserva-
tion. After sucrose sinking, the spheroids were washed 
three times in PBS for three minutes each time prior to 
the permeabilisation step. In order to permeabilise the 
tissue, the antibodies could reach their epitopes within 
the cell membrane and to prevent non-specific stain-
ing, the samples were incubated for 60  min in permea-
bilisation-blocking solution of 2% normal goat serum 
(NGS) in 0.1% Triton X100 and PBS. Then, the spheroids 
were incubated in a solution of permeabilisaton-block-
ing solution containing the primary antibodies for 48 h. 
The samples were washed three times for three minutes 
in PBS and incubated with permeabilisation-blocking 
solution containing the secondary antibodies and DAPI 
(nuclear staining) for two hours and kept in darkness to 
prevent bleaching of the fluorophores.
Cleared spheroids
The hCS  were first washed in PBS for 3  min and then 
fixed in 4% formaldehyde solution in 4% sucrose-PBS 
overnight at 4  °C. Fixation solution was then removed 
and stored in sucrose 30% (w/v) overnight at 4 °C. Sphe-
roids were then permeabilised and blocked using a perm/
block solution (0.6 M glycine, 0.2% Triton X-100, 2% goat 
serum, 20% DMSO in PBS) overnight at room tempera-
ture (RT). Samples were permeabilised for this length of 
time in order to facilitate antibody penetrance into large 
tissues. The samples were washed twice in PBST for 1 h 
each time at RT. Primary antibody was made using an 
‘antibody solution’ (0.2% Tween-20, 5% DMSO, 2% goat 
serum, 0.01% sodium azide in PBS). Spheroids were 
incubated in antibody solution for 2  days. After 2  days, 
spheroids were again washed in PBST for 1 h each at RT. 
Secondary antibody solution with added Hoechst (for 
nuclear stain) was made using the same ‘antibody solu-
tion’ as before. This was incubated similarly for 2 days at 
RT, protecting from light. Following secondary staining, 
cells were washed with PBST and stored in PBS before 
clearing and mounting for ALSM imaging.
Clearing and mounting of intact hCS
To mount samples a set of homemade sample mounts 
were created by bonding a 46 mm square weighing boat 
(Fisherbrand Cat No. 12942860) to a standard 75  mm 
microscopy slide using cyanoacrylate glue (Additional 
file 1: Figure 7). A silicone rubber plinth was constructed 
by first casting silicone rubber (9 parts reagent to 1 part 
catalyst) in a flat vessel (petri dish) with a textured base 
(60 grit sandpaper) to a depth of approximately 5  mm 
and left to cure for at least 24  h. Once this had set, a 
4 mm cylinder was punched using a hollow hole punch 
tool. The cylinder was bonded to the middle of the weigh-
ing boat with the textured surface facing upwards using 
cyanoacrylate glue and left to set for a few hours before 
use. The silicone rubber cylinder formed the imaging 
plinth for samples to be positioned on allowing lenses to 
lower around plinth and sample without collision to base 
of the weighing boat (Additional file 1: Figure 7).
In order to place whole hCSs on to the imaging plinth, 
1.2% w/v agarose in water was melted and a small volume 
(less than 50 µl) was placed on to the plinth and the sphe-
roid was positioned in the top of the still liquid agarose 
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shortly after allowing agarose to solidify around the sphe-
roid and holding it still for imaging.
Mounted spheroids were then cleared using the 
ScaleSQ5 protocol published by Hamma et al. 2015[31]. 
In this method, clearing was performed by incubating 
hCSs into ScaleSQ(5) solution (Additional file 1: Table 2) 
for 2 h at 37 °C. This was followed by submersion of the 
cleared tissue in mounting media ScaleS4(0) (Additional 
file 1: Table 2) for at least 2 h at room temperature. The 
mounting media had a refractive index (RI) = 1.437.
Confocal microscopy
A Leica laser scanning confocal microscope (TCS-SP5) 
was used to image Day 7 and 17 2D cultures, as well as 
Day 7 whole-mount and Day 17 cryosectioned sphe-
roids. Leica’s LAS AF software was used to set up and 
acquire multiple channels of singular planes and Z stacks 
at a resolution of 1024 × 1024 px. 405 nm (DAPI; blue), 
488 nm (green), 561 nm (red) and 633 nm (far-red) lasers 
were used to generate images in colour channels. Smart 
gain was used to adjust the different channels to a simi-
lar intensity to highlight fluorescent staining. 2D cultures 
were acquired at 63 × magnification in oil immersion (NA 
1.4), whereas 3D cultures were imaged at 40 × magnifica-
tion in oil immersion (NA 1.3) to encompass a wider field 
of view. A line average of three was used in each channel 
during point scanning to reduce appearances of random 
background signal caused by light scattering, therefore 
increasing the quality of acquisition.
Lightsheet microscopy
An upright Aurora™ M Squared single photon Airy beam 
light-sheet microscope [27] was used to perform the 
light-sheet imaging on the organoid samples. The fluoro-
phore excitation was delivered with a 10 × water immer-
sion illumination objective (Olympus UMPLNFLN 
10 × NA 0.30), and emission was captured orthogonal 
to the excitation plane using a 20 × water immersion 
detection objective (Olympus UMPLNFN 20 × NA 0.50) 
to provide a lateral resolution of 670  nm. The emis-
sion light passed through a filter wheel before images 
were captured using a sCMOS camera (Orca Flash 4.0 
v2) with a FOV of 600  µm. Three-dimensional volumes 
were acquired in step sizes of 0.4 µm by XZ translation 
of the sample through the focal plane and outputted 
stacks were deconvoluted to provide an axial resolution 
of ~ 870 nm. Samples were excited using a 405 nm (DAPI; 
blue), 488 nm (green), 561 nm (red) and 640 nm (far-red) 
lasers and camera exposure rate adjusted to generate 
optimal S/N for multi-colour images. Objective working 
distance was 3.5 mm which allowed ample space for posi-
tioning of samples.
Image acquisition with lightsheet microscopy
Preparation and collection of PSF for deconvolution/image 
processing with tetraspeck beads
In order to process the data with the M-Squared Lasers 
Deconvolution software, a volume of data containing 
fluorescent microspheres was collected with identical 
optical and spatial parameters (wavelengths for excita-
tion and emission as well as xy pixel size and z step size) 
as the collected specimen data to be able to produce a 
calibrated point-spread function (PSF). To produce a 
suspension of fluorescent microspheres adequate for this 
purpose, 1.2  µl of stock solution of 0.5  µm fluorescent 
microspheres (Invitrogen Tetraspeck 0.5  µm—Cat No. 
T7281) was added to 100 µl of molten agarose (1.2% w/v) 
and the mixture was completely mixed by pipette action 
before dispensing. 50  µl of the mixture was drawn, and 
a dome of agarose was placed on a clean sample mount 
and allowed to solidify before continuing. Mounted bead 
suspensions were then placed in the corresponding imag-
ing medium (PBS or ScaleS0(4)) and either used imme-
diately (PBS) or left overnight. For samples or beads in 
ScaleS0(4) at least one further solution change was then 
made a few hours before imaging to allow solutions to 
properly equilibrate and allow any residual water from 
the agarose to be completely removed.
Acquisition of bead fluorescence volumes was per-
formed by positioning the bead preparation in the focal 
plane of the lenses with the motorised stage, and first 
checking excitation beam was visible and focussed by 
halting scanning mirrors to produce a static beam image 
and observing position and shape of formed image and 
adjusting focus of excitation and detection objectives 
so that the correct focussed beam shape was observed. 
Once this was satisfied, the scanning mirrors were reac-
tivated and images were collected with excitation power 
and camera integration time sufficient that the peak 
image intensity of beads was measured to be at least 10% 
of the total camera bit depth (16bit—65,535) producing 
sufficient signal to noise ratio for software to automati-
cally locate beads from the data set. This criterion was 
met for each combination of excitation wavelength and 
emission filter combination required to image a sample 
and a volume of at least 100 µm depth of images spaced 
0.4 µm apart in focus. The stage was translated in the yz 
axis with a dedicated stage driver for this axis as this was 
the perpendicular direction to the focus of the detec-
tion objective. These data were analysed and processed 
by software to obtain the PSF of the imaging setup to be 
used for deconvolution. This generated a unique PSF and 
calibration file used on each date of data acquisition and 
used to deconvolve datasets of sample fluorescence.
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Sample image acquisition, deconvolution and presentation
Samples once mounted were positioned in the focus of 
the objectives, and data were collected by translation 
of the motorised stage using the yz driver. Laser power 
and camera integration times were set to provide suf-
ficient contrast and intensity aiming to minimise total 
integration time while not compromising signal. The raw 
data were then passed to M-Squared Lasers proprietary 
deconvolution software to process for deconvolution 
and removal of Airy pattern in data. Richardson–Lucy 
deconvolution was processed with at least 100 iterations, 
and a final datafile is produced for each channel. These 
were then combined in Nikon Elements (version 5.02) to 
overlay channels and produce three-dimensional renders 
as shown in figures. In some instances, Volocity 6.3.1 
(PerkinElmer) or ClearVolume (ImageJ plugin—https ://
image j.net/Clear Volum e) were used to produce 3D ren-
ders which was chosen only for convenience at the time.
Morphological measurements of lumen volume (Fig. 6) 
were performed using Volocity 6.3.1 (PerkinElmer) where 
an object is defined by use of the built-in “find-objects” 
method and selecting an intensity value to set the thresh-
old for volumetric regions based on the channel used. An 
arbitrary volume of more than 150 µm3 was chosen from 
the dataset, and objects smaller than this were discarded.
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